Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2003
06/10/2003CA2232775C Acyl compounds
06/10/2003CA2225156C Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
06/10/2003CA2192354C Corticotropin releasing factor against antagonist
06/10/2003CA2055670C Retroviral protease inhibiting compounds
06/09/2003WO2003002536A1 Unsymmetrical cyclic diamine compound
06/05/2003WO2003046200A2 Methods for ligand discovery
06/05/2003WO2003045944A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003WO2003045942A2 Chemokine receptor antagonists and methods of use thereof
06/05/2003WO2003045941A1 Pyridine and pyrimidine derivatives
06/05/2003WO2003045940A2 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003WO2003045939A1 Processes for the preparation of substituted bicyclic derivatives for the treatment of abnormal cell growth
06/05/2003WO2003045937A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045924A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003WO2003045921A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045919A2 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/05/2003WO2003045918A1 Piperidine-based mch antagonists for treatment of obesity and cns disorders
06/05/2003WO2003045913A1 Benzamide derivatives, processes for their preparation, and their pharmaceutical use
06/05/2003WO2003045912A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
06/05/2003WO2003045395A1 Quinazoline derivatives for the treatment of t cell mediated diseases
06/05/2003WO2003045382A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003WO2003045379A1 Hydrazonopyrazole derivatives and their use as therapeutics
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003014094A3 Heterocyclic aryl sulphonamides
06/05/2003WO2002091988A3 Novel processes for the preparation of adenosine compounds and intermediates thereto
06/05/2003WO2002085843A3 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/05/2003WO2002048137A3 Substituted heterocyclic phthalic acid diamide arthropodicides
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030105328 High effectiveness and high oral bioavailability; for example, 6-(4-Acetamidophenyl)-3-isobutyryl-5-(N-benzyl-N-methylaminomethyl)-1-(2',6'-difluorobenzyl)-1,4-dihydro-4-oxoquinoline
06/05/2003US20030105150 Method of treating of demyelinating diseases or conditions
06/05/2003US20030105142 Amide derivatives useful as inhibitors of the production of cytokines
06/05/2003US20030105139 Indole derivatives as 5-HT receptor antagonist
06/05/2003US20030105137 Tryptase inhibitor; antiinflamamtory agents, antiallergens
06/05/2003US20030105136 Antihistamiones, respiratory system disorders
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105133 4-Substituted piperidine analogs and their use as subtype selective NMDA receptor, antagonists
06/05/2003US20030105131 Aids therapy; antiinflamamtory agents; antiallergens; rheumatic diseases
06/05/2003US20030105129 Chemical compounds
06/05/2003US20030105124 Substituted benzolactam compounds
06/05/2003US20030105122 Compounds for enhancing chemotherapy
06/05/2003US20030105119 For therapy of inflammation, immune disorders, asthma, chronic obstructive pulmonary disease (COPD), multiple sclerosis (MS), inflammatory bowel disease (IBD); side effect reduction
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105105 As anticoagulant agents for therapy and prophylaxis of thromboembolic disorders
06/05/2003US20030105094 For therapy of metabolic disorder, an eating disorder or diabetes
06/05/2003US20030105091 Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105085 Antagonists of MCP-1 function and methods of use thereof
06/05/2003US20030105083 Drug combination for the treatment of depression and related disorders comprising mirtazapine
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003CA2812024A1 Methods for ligand discovery
06/05/2003CA2468716A1 Heterocyclic amide compounds as apolipoprotein b inhibitors
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2468010A1 Benzazepine derivatives and their use as 5-ht ligands
06/05/2003CA2467874A1 N-ureido-piperidines as antagonists viii for ccr-3 receptor
06/05/2003CA2467870A1 Substituted aryl 1,4-pyrazine derivatives
06/05/2003CA2467565A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
06/05/2003CA2467165A1 Therapeutic compounds for treating dyslipidemic conditions
06/05/2003CA2464107A1 Process for the synthesis of amine ethers from secondary amino oxides and uses
06/05/2003CA2464094A1 Methods for ligand discovery
06/04/2003EP1315728A1 Process for the preparation of vitronectin receptor antagonists
06/04/2003EP1315715A1 Quinazoline derivatives as kinase inhibitors
06/04/2003EP1315714A2 Quinazoline derivatives as alpha-1 adrenergic antagonists
06/04/2003EP1315708A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315703A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor
06/04/2003EP1315699A2 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
06/04/2003EP1315698A1 Pyrrolidines as inhibitors of neuraminidases
06/04/2003EP1315496A2 The treatment of inflammatory disorders
06/04/2003EP1315490A2 A method for treating allergies using substituted pyrazoles
06/04/2003EP1282609A4 Piperazinedione compounds
06/04/2003EP1165543B1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
06/04/2003EP1144407B1 Cyclic guanidine derivatives and their use as pesticides
06/04/2003EP1051413B1 Quinoline derivatives as antibacterials
06/04/2003EP1017395A4 Method for treating premenstrual or late luteal phase syndrome
06/04/2003EP0968208B1 Quinoline and quinazoline compounds useful in therapy, particularly in the treatment of benign prostatic hyperplasia
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0919233B1 Therapeutic agent for kidney diseases
06/04/2003EP0901487B1 2,3,6 trisubstituted-4(3h)-quinazolinones
06/04/2003EP0882023B1 Histamine h 3 receptor ligands
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0820452B1 Carbonyl-piperazinyl and piperidinil compounds which inhibit farnesyl protein transferase
06/04/2003EP0819120B1 Tricyclic compounds useful for inhibition of farnesyl protein transferase
06/04/2003EP0814839B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
06/04/2003EP0775135B1 N-substituted 3-azabicyclo (3.2.0)heptane derivatives useful as neuroleptics
06/04/2003EP0775120B1 Novel pyrimidine derivatives and processes for the preparation thereof
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003EP0773940B1 Process for synthesis of substituted sulphoxides
06/04/2003CN1422266A Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
06/04/2003CN1422256A Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredent
06/04/2003CN1421439A Process for producing insecticide intermediate
06/04/2003CN1110497C Di-or triaza-spiral [4,5] decane derivative
06/04/2003CN1110495C Arylalkyl diazinones, its preparing method and its medical preparation
06/04/2003CN1110486C Substituted 2-amino-4-alkylamino-1,3,5-triazines as herbicides
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110482C Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
06/04/2003CN1110478C Biocidal benzylbiphenyl derivatives
06/04/2003CN1110305C Naphthyl-substituted benzimidazole derivatives as anticoagulants
06/03/2003USRE38132 Phenylpyrrolidines, phenylimidazolidines,3-phenyl-1,3-oxizolidines and 3-phenyl-1,3-thiazolidines and their use in the treatment of inflammatory disease
1 ... 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 ... 1080